Join Us in Transforming Alzheimer's Treatment

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Started: Feb 4, 2025

Last Updated: Aug 5, 2025

Status

Enrolling

Phase

Age

55 - 85 years

Enrollment Goal

760

Study Drug:

Buntanetap (formerly Posiphen)

Key Inclusions:

MMSE 21-28
‍
Positive for plasma pTau217

Primary Endpoints:

ADAS-Cog13
‍
ADCS-iADL

Clinicaltrials.gov ID:

NCT06709014

THE STUDY AIMS TO ANSWER:

1. Does buntanetap improve cognition as measured by ADAS-Cog13?

2. Does buntanetap improve function as measured by ADCS-iADL?

3. What medical issues do participants have, if any, when taking buntanetap?

‍

TREATMENT

Participants will take buntanetap (30mg) or placebo every day for 18 months.

‍

OTHER ENDPOINTS‍

In addition to primary endpoints, the study will also measure MMSE, CGI-S, CDR, and volumetric MRI (hippocampus and whole brain).

‍

TIMELINE

The study will have a 6-month read-out to measure symptomatic improvement and a 18-month read-out to measure potential disease-modifying response.

‍

Find more information at ClinicalTrials.gov

Dynamic Map Instructions (Delete This)

Don't delete "cru-ncf"-elements

Elements with “cru-ncf-…” classes contain essential attributes required for Dynamic Map to function properly. Please do not delete these elements.

Style in Webflow, modify in Dynamic Map App

Use the Dynamic Map App from Webflow’s App Store to adjust your map settings. All styling can be managed directly in Webflow. Refer to the Style Guide below the map to customize elements provided by Dynamic Map.

In case of an issue...

... open the Dynamic Map App, click “Refresh,” then “Insert Code,” and follow the provided instructions. If this doesn’t resolve the issue, refer to our Help Center for assistance.

Important Links

Dynamic Map App

Help Center

License Settings

About Dynamic Map for Webflow [by No Code Flow]

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Abington

1151 Old York Rd. Suite 200, 19001

215-957-9250

Amherst

3980 Sheridan Dr. NY 14226

888-555-8884

Anaheim

1020 S. Anaheim Blvd Suite 316, 92805

714-999-6688

Arlington

1635 N George Mason Dr, Arlington, VA 22205

571-749-5807

Atlantis

30 John F Kennedy Dr STE 203, FL 33462

Austin

3215 Steck Ave Suite 200/202, 78757

512-407-8628

Aventura

21000 NE 28th Ave. Ste 204, 33180

954-889-3257

Basalt

350 Market St. Ste 001, CO 81621

970-927-1141

Beavercreek

3572 Dayton- Xenia Rd. Suite 217, 45432

208-346-8900

Bennington

357 Shields Dr. 05201

802-447-1409

Boca Raton

1601 Clint Moore Rd. Ste 120, 33487

561-939-0333

Brooklyn

3044 Coney Island Ave Suite 201, 11235

718-616-2230

Canoga Park

22030 Sherman Way Suite 101 and 110, 91303

818-253-8966

Centerville

6611 Clyo Rd. Suite E, 45459

937-208-8298

Chandler

3190 S. Gilbert Rd. Ste 5, 85286

520-239-2636

Chesterfield

17998 Chesterfield Airport Rd. #100, 63005

636-220-1200

Chicago

142 E. Ontario St. Suite 1400, 60611

312-971-3318

Chicago

5149 North Ashland Ave, 60640

773-275-3500

Chicago

2923 N. California, Suite 220, IL 60618

773-997-1000

Clermont

17309 Pagonia Rd, 34711

321-500-5252

Cordova

8000 Centerview Pkwy Suite 500, 38018

901-747-1111

Dartmouth

75 Brandt Ave. MA 02747

508-300-9803

Daytona Beach

2595 West International Speedway Blvd, 32114

407-447-4342

Decatur

755 Commerce Dr. Suite 200, 30030

404-475-0552

Durham

932 Morreene Rd. , 27705

919-660-3978

East Providence

1018 Waterman Ave, 02914

401-435-8950

El Paso

7100 Westwind Dr. Suite 300C, 79912

915-974-2200

Encino

17777 Ventura Blvd Ste 235, 91316

402-238-6395

Englewood

701 E. Hampden Ave Ste 510, 80113

303-867-5473

Fairfax

8316 Arlington Blvd, 22031

703-520-9703

Farmington Hills

28555 Orchard Lake Rd. Ste 200, 48334

248-957-8944

Flowood

3531 Lakeland Dr. Brentwood Plaza Ste 1060, 39232

601-420-5812

Fort Myers

14271 Metropolis Ave, 33912

239-939-7777

Foxboro

9 Payson Rd. Suite 100, MA 2035

781-551-5812

Gainesville

2350 Limestone Pkwy, 30501

678-928-6476

Hallandale Beach

911 E. Hallandale Beach Blvd, 33009

954-455-5757

Honolulu

2230 Liliha St. #104, 96817

808-564-6141

Houston

18400 Katy Fwy Ste 420, 77094

281-410-8952

Hyde Park

271-11 76th Ave, 11040

718-289-2103

Imperial

2417 Marshall Ave, Suite 1, 92251

760-545-0346

Independence

4801 Acorn Dr. OH 44131

216-526-1843

Indianaopolis

7250 Clearvista Dr, Suite 225, 46256

317-537-6056

Jacksonville

4085 University Blvd South Suite 1, 32216

904-732-6682

LadyLake

8577 NE 138th Ln, 32159

407-395-4096

Lake Charles

600 Bayou Pines Blvd. 70601

337-602-6642

Lake Success

1991 Marcus Ave Ste 110, 11042

516-466-4700

Lake Worth

130 John F Kennedy Dr, Suite 203, 33462

561-968-2933

Lakeland

2135 Harden Blvd, 33803

863-940-2087

Las Vegas

4488 S. Pecos Rd. 89121

702-832-1369

Maitland

1551 Sandspur Rd. 32751

407-636-4031

Maitland

101 Southhall Lane Suite 150, 32751

407-500-5252

Matthews

10801 Monroe Road Suite #100, 28105

704-364-4000

Media

107 Chesley Dr. Unit 4, 19063

610-891-9024

Melbourne

7000 Spyglass Cr #320, 32940

407-680-0534

Merritt Island

60 Fortenberry Rd, 32952

386-785-8009

Metairie

4420 Conlin St. 70006

504-934-8424

Miami

5200 NE 2nd Ave, FL 33137

305-762-1487

Moosic

340 Montage Mountain Rd. PA 18507

570-346-3686

Naples

3200 Bailey Lane Suite 250, 34102

239-529-6780

Nashville

321 Homestead Rd, Nashville, TN 37207

615-425-0723

New Port Richey

5604 Gulf Dr. 34652

727-849-4131

New York

7 Grammercy Park W, 10003

646-440-4240

Norwalk

71 East Ave Ste 1, 06851

203-838-0070

Oklahoma City

3555 NW 58th Ste 800, 73112

405-602-3939

Orlando

13563 Narcoossee Rd. Ste 110, 32832

689-488-9112

Phoenix

2601 N 3rd St #125, Phoenix, 85004

602-274-9500

Pikesville

1314 Bedford Ave Ste 205, 21208

410-602-1440

Plymouth

5 Resnik Road, Suite 205, 02360

816-820-4109

Plymouth Meeting

920 Germantown Pike Suite 102, PA 19462

Portland

2701 NW Vaughn St. Ste 350, 97210

503-972-9822

Princeton

256 Bunn Dr. Suite 6, NJ 857-453-8113

857-453-8113

Raleigh

4201 Lake Boone Trail Ste 001, 27607

919-800-5154

Round Rock

16040 Park Valley Dr. Suite B100, 78681

512-218-1222

San Marcos

838 Nordahl Rd. Suite 200, 92069

619-485-9892

Scottsdale

9977 N 95th St. Suite 101, 85258

480-661-5024

Springfield

95 Frank B. Murray St. 01103

413-305-1144

Springfield

751 N. Rutledge St. Suite 3100, 62702

217-545-6829

Staten Island

260 Christopher Ln, 10314

718-317-5522

Summerville

5500 Front St. Ste 230, 29483

216-329-9910

Syracuse

1101 Erie Blvd E. Suite 201, 13210

315-904-5004

Toms River

9 Mule Rd. Ste E8-9, 8755

732-341-9500

West Long Branch

185 State Hwy 36, Bldg A Ste 115, 07764

732-807-4700

Wichita

1100 N. St. Francis Ste 300, KS 37214

316-268-6055

Wichita Falls

3300 Seymour Highway, 76309

940-322-1131

Winter Park

2233 Lee Rd Ste 101, 32789

689-488-9124

Dynamic Map Style Guide (Don't Delete)

Please modify your styling elements here to change their appearance on the live website. The styleguide is invisible on the published site.

CMS List Item

Change the active state for your list item

Default State

List Item Default

Active State [add class "active"]

List Item Active

Filter Reset / Empty State

Style your empty state

There are no items using this filter combination.

Reset Filter

Filter Address Search

Change the active state for your address search

Default State

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Active State [add class "active"]

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Filter Chip

Change the active state for your filter chip

Default State

Filter Chip

Active State [add class "active"]

Filter Chip Active

Map Location Pin

Change pin style and states

Default State

Hover State [add class "hover"]

Active State [add class "active"]

Ask us about our clinical trials

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

IRB approved Alzheimer Study Flyer: Buntanetap in Treating Alzheimer’s and Parkinson’s Disease

The data from our phase 2 study in Alzheimer’s and Parkinson’s patients was published in JPAD (Journal of Prevention of Alzheimer’s Disease) and we have attached the paper. Here is a summary of what we found and why we have progressed our drug into phase 3.
Buntanetap is an orally available small molecule that inhibits the translation of multiple neurotoxic aggregating proteins only under conditions where their translation is elevated – in sick nerve cells. Because it only affects these neurotoxic proteins when they are overexpressed, it restores their normal levels without affecting other proteins and restores homeostasis in the brain.
Both Alzheimer’s disease and Parkinson’s disease have been shown to have mixed pathology and mixed proteinopathy. All four neurotoxic aggregating proteins are present in the brain of Alzheimer and Parkinson patients – Aβ forms plaques, tau forms tangles, alpha-synuclein forms Lewy bodies, and TDP43 forms its aggregates.

Buntanetap inhibits translation of all the above four neurotoxic proteins, thus is well positioned to treat both diseases, which is an advantage compared to removing a single neurotoxic protein alone. In a double-blind, placebo-controlled, multi-center phase 2, study we enrolled 14 early AD and 54 early PD participants who were treated for 25 days with buntanetap or placebo. Buntanetap was safe and well tolerated. Biomarker data indicated a trend in lowering levels of neurotoxic proteins and inflammatory factors and improving axonal integrity and synaptic function in both AD and PD cohorts, confirming target and pathway engagement of buntanetap. Psychometric tests showed statistically significant improvements in ADAS-Cog11 and WAIS coding in AD patients and MDS-UPDRS and WAIS coding in PD patients. These findings support the hypothesis that lowering levels of neurotoxic aggregating proteins leads to stabilization and improvement in cognition and motor function.
Please look us up at ClinicalTrials.gov

Stay Updated with Annovis Bio, Inc.
(NYSE: ANVS)

Join the Annovis Bio Newsletter to receive the latest updates on our groundbreaking research and developments in neurodegenerative diseases like Alzheimer's and Parkinson's

Join Us in Transforming Alzheimer's Treatment

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Dynamic Map Instructions (Delete This)

Don't delete "cru-ncf"-elements

Style in Webflow, modify in Dynamic Map App

In case of an issue...

Important Links

Locations

Dynamic Map Style Guide (Don't Delete)

CMS List Item

Filter Reset / Empty State

Pop-Up

Tooltip (Don't Delete)

Filter Address Search

Filter Chip

Map Location Pin

Ask us about our clinical trials

IRB approved Alzheimer Study Flyer: Buntanetap in Treating Alzheimer’s and Parkinson’s Disease

Stay Updated with Annovis Bio, Inc.
(NYSE: ANVS)

Helpful Links

ANNOVIS BIO

CLINICAL TRIALS

INVESTOR RELATIONS

Join Us in Transforming Alzheimer's Treatment

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Dynamic Map Instructions (Delete This)

Don't delete "cru-ncf"-elements

Style in Webflow, modify in Dynamic Map App

In case of an issue...

Important Links

Locations

Dynamic Map Style Guide (Don't Delete)

CMS List Item

Filter Reset / Empty State

Pop-Up

Tooltip (Don't Delete)

Filter Address Search

Filter Chip

Map Location Pin

Ask us about our clinical trials

IRB approved Alzheimer Study Flyer: Buntanetap in Treating Alzheimer’s and Parkinson’s Disease

Stay Updated with Annovis Bio, Inc. (NYSE: ANVS)

Helpful Links

ANNOVIS BIO

CLINICAL TRIALS

INVESTOR RELATIONS

Stay Updated with Annovis Bio, Inc.
(NYSE: ANVS)